Li, Chengtai. “Should CRISPR-Cas9 Be Used in Human Embryos to Eliminate Genetic Diseases? Public Attitudes and Benefit–Risk Analysis”. MedScien, vol. 4, no. 1, Feb. 2026, p. 6812, doi:10.61173/as39n470.